• We are a biotech company in
    infectious diseases with
    two marketed products.

  • Dedicated to innovation in
    vaccine research & development.

  • Valneva covers the full
    value chain from bench
    to market.

Welcome to Valneva

Joining forces to create a European biotech leader in vaccines


— June 26, 2015

Valneva announces successful outcome of its AGM and renewal of the term of office of its management board members
Read more

— Stock information



—News, June 22, 2015

Valneva takes direct control over Marketing and Distribution of IXIARO® to increase margin and profitability

 Read more

— Financial calendar


All dates     


play video Valneva's CEO Thomas Lingelbach
comments on Group Strategy

– Upcoming conferences and fairs

Munich, Germany 
2–4 November, 2015 

Jefferies Autumn 2015 Global Healthcare Conference

London, UK
18-19 November, 2015

J.P. Morgan 33rd Annual Healthcare Conference
San Francisco, U.S.
12-16 January, 2015


European pure vaccine player with international footprint.

Please update your browser...